Mechanisms of Sensitivity and Resistance of Multiple Myeloma to NK Cells can potentially leading to new treatments

Sara Gandolfi, from the Hematology Research Unit in Helsinki, presented research at the EHA 2024 conference on how natural killer (NK) cells interact with hematologic cancers like multiple myeloma. Her studies aim to uncover mechanisms behind tumor cell resistance to NK cells, potentially leading to new treatments targeting these pathways.